Surrozen, Inc. (SRZN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Craig C. Parker
Employees:
80
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
650-475-2820

Surrozen, Inc. discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.

Data derived from most recent annual or quarterly report
Market Cap 27.009 Million Shares Outstanding35.123 Million Avg 30-day Volume 216.838 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.38
Price to Revenue0.0 Debt to Equity0.0511 EBITDA-48.142 Million
Price to Book Value0.9115 Operating Margin0.0 Enterprise Value-4.208 Million
Current Ratio9.559 EPS Growth0 Quick Ratio9.059
1 Yr BETA 0.7213 52-week High/Low 3.73 / 0.34 Profit Margin0.0
Operating Cash Flow Growth-19.0443 Altman Z-Score-0.5357 Free Cash Flow to Firm 0
View SEC Filings from SRZN instead.

View recent insider trading info

Funds Holding SRZN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRZN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARKER CRAIG C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2023-03-01 3

WILLIAMS CHARLES O CHIEF FINANCIAL OFFICER

  • Officer
0 2023-02-01 3

YEH WEN-CHEN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2023-02-01 3

VANHOVE GEERTRUI CHIEF MEDICAL OFFICER

  • Officer
32,412 2022-12-15 2

BLUTT MITCHELL J MD

SOFFER BENNY

LIVINGSTON KEVIN HAROLD

CONSONANCE CAPITAL MANAGEMENT LP

CONSONANCE CAPMAN GP, LLC

CONSONANCE LIFE SCIENCES

  • 10% Owner
0 2022-12-14 1

CHAI CHRISTOPHER Y

  • Director
20,000 2022-06-07 1

KUTZKEY TIM

  • Director
  • 10% Owner
20,000 2022-06-07 1

WOODHOUSE DAVID J

  • Director
20,000 2022-06-07 1

BERKENBLIT ANNA

  • Director
20,000 2022-06-07 1

LIN SHAO-LEE

  • Director
20,000 2022-06-07 1

HAAK-FRENDSCHO MARY

  • Director
20,000 2022-06-07 1

ROTHENBERG MACE

  • Director
20,000 2022-06-07 1

BLUTT MITCHELL J MD

CONSONANCE CAPITAL MANAGEMENT LP

CONSONANCE CAPMAN GP, LLC

  • 10% Owner
6,382,500 2021-08-11 1

COLUMN GROUP III GP, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III, LP

  • 10% Owner
9,248,129 2021-08-11 0

CONSONANCE LIFE SCIENCES

  • FORMER 10% HOLDER
1,885,000 2021-08-11 0

LIVINGSTON KEVIN HAROLD

  • FORMER CHIEF FINANCIAL OFFICER
1,885,000 2021-08-11 0

SOFFER BENNY

  • FORMER DIRECTOR
1,885,000 2021-08-11 0

BLUTT MITCHELL J MD

  • Director
0 2020-11-18 1

SANTEL DONALD J

  • Director
0 2020-11-18 0

CONSONANCE CAPITAL MANAGEMENT LP

CONSONANCE CAPMAN GP, LLC

CONSONANCE CAPITAL OPPORTUNITY FUND MANAGEMENT LP

  • Director
0 2020-11-18 0

SOFFER GAD

  • Director
0 2020-11-18 0

HAQQ CHRISTOPHER

  • Director
0 2020-11-18 0

JARRETT JENNIFER

  • Director
0 2020-11-18 0

HOUSE JOSHUA CORY VP BUSINESS DEVELOPMENT

  • Officer
0 2020-11-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PARKER CRAIG C - Director - Officer CHIEF EXECUTIVE OFFICER

2023-03-02 13:03:42 -0500 2023-03-01 A 405,000 a 405,000 direct

WILLIAMS CHARLES O - Officer CHIEF FINANCIAL OFFICER

2023-02-02 16:32:00 -0500 2023-02-01 A 125,000 a 125,000 direct

YEH WEN-CHEN - Officer CHIEF SCIENTIFIC OFFICER

2023-02-02 16:28:46 -0500 2023-02-01 A 125,000 a 125,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SURROZEN INC SRZN 2023-03-24 22:15:03 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 21:45:03 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 21:15:03 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 20:45:03 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 20:15:04 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 19:45:03 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 19:15:04 UTC -17.8457 22.6657 1000
SURROZEN INC SRZN 2023-03-24 18:45:04 UTC -17.8721 22.6921 1000
SURROZEN INC SRZN 2023-03-24 18:15:03 UTC -17.8721 22.6921 1000
SURROZEN INC SRZN 2023-03-24 17:45:03 UTC -17.8721 22.6921 10000
SURROZEN INC SRZN 2023-03-24 17:15:03 UTC -17.8721 22.6921 15000
SURROZEN INC SRZN 2023-03-24 16:45:03 UTC -17.7523 22.5723 15000
SURROZEN INC SRZN 2023-03-24 16:15:03 UTC -17.7523 22.5723 6000
SURROZEN INC SRZN 2023-03-24 15:45:03 UTC -17.7523 22.5723 7000
SURROZEN INC SRZN 2023-03-24 15:15:03 UTC -17.7523 22.5723 8000
SURROZEN INC SRZN 2023-03-24 14:45:03 UTC -18.0023 22.5723 8000
SURROZEN INC SRZN 2023-03-24 14:15:03 UTC -18.0023 22.5723 8000
SURROZEN INC SRZN 2023-03-24 13:45:03 UTC -18.0023 22.5723 8000
SURROZEN INC SRZN 2023-03-24 13:15:04 UTC -18.0023 22.5723 8000
SURROZEN INC SRZN 2023-03-24 12:45:03 UTC -18.0023 22.5723 8000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments